Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: MagnEss Gly
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
MagnEss Gly 121.25mg/5ml (5mmol/5ml) oral solution
0905013G0BHAFDK
|
MagnEss Gly | Magnesium glycerophosphate | Nutrition and Blood | 16 |
|
MagnEss Gly 97.2mg/5ml (4mmol/5ml) oral solution
0905013G0BHAEDJ
|
MagnEss Gly | Magnesium glycerophosphate | Nutrition and Blood | 9 |
|
MagnEss Gly 97.2mg (4mmol) capsules
0905013G0BHADA4
|
MagnEss Gly | Magnesium glycerophosphate | Nutrition and Blood | 3 |
|
MagnEss Gly 97.2mg (4mmol) chewable tablets
0905013G0BHAADE
|
MagnEss Gly | Magnesium glycerophosphate | Nutrition and Blood | 2 |
|
MagnEss Gly 48.6mg (2mmol) capsules
0905013G0BHACBM
|
MagnEss Gly | Magnesium glycerophosphate | Nutrition and Blood | 1 |
|
MagnEss Gly 39.5mg (1.6mmol) capsules
0905013G0BHABDB
|
MagnEss Gly | Magnesium glycerophosphate | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.